1. Home
  2. ACHV vs ARAY Comparison

ACHV vs ARAY Comparison

Compare ACHV & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • ARAY
  • Stock Information
  • Founded
  • ACHV N/A
  • ARAY 1990
  • Country
  • ACHV United States
  • ARAY United States
  • Employees
  • ACHV N/A
  • ARAY N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ARAY Medical/Dental Instruments
  • Sector
  • ACHV Health Care
  • ARAY Health Care
  • Exchange
  • ACHV Nasdaq
  • ARAY Nasdaq
  • Market Cap
  • ACHV 167.6M
  • ARAY 170.1M
  • IPO Year
  • ACHV N/A
  • ARAY 2007
  • Fundamental
  • Price
  • ACHV $3.17
  • ARAY $1.70
  • Analyst Decision
  • ACHV Strong Buy
  • ARAY Strong Buy
  • Analyst Count
  • ACHV 1
  • ARAY 1
  • Target Price
  • ACHV $12.00
  • ARAY $5.00
  • AVG Volume (30 Days)
  • ACHV 727.0K
  • ARAY 938.2K
  • Earning Date
  • ACHV 11-06-2025
  • ARAY 11-05-2025
  • Dividend Yield
  • ACHV N/A
  • ARAY N/A
  • EPS Growth
  • ACHV N/A
  • ARAY N/A
  • EPS
  • ACHV N/A
  • ARAY N/A
  • Revenue
  • ACHV N/A
  • ARAY $458,505,000.00
  • Revenue This Year
  • ACHV N/A
  • ARAY $5.70
  • Revenue Next Year
  • ACHV N/A
  • ARAY $4.05
  • P/E Ratio
  • ACHV N/A
  • ARAY N/A
  • Revenue Growth
  • ACHV N/A
  • ARAY 2.68
  • 52 Week Low
  • ACHV $1.84
  • ARAY $1.14
  • 52 Week High
  • ACHV $5.31
  • ARAY $2.95
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 51.96
  • ARAY 51.55
  • Support Level
  • ACHV $3.07
  • ARAY $1.58
  • Resistance Level
  • ACHV $3.48
  • ARAY $2.10
  • Average True Range (ATR)
  • ACHV 0.15
  • ARAY 0.11
  • MACD
  • ACHV -0.01
  • ARAY -0.00
  • Stochastic Oscillator
  • ACHV 34.85
  • ARAY 21.58

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: